tiprankstipranks
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX

XORTX Therapeutics Inc (XRTX) Ownership - Who Owns XORTX Therapeutics Inc?

33 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 09, 2024
Anthony J Giovinazzo
Chairman,director
Bought$7091
Feb 21, 2024
Allen Warren Davidoff
President & Chief Executive Officer
BoughtC$30000
Dec 29, 2023
Anthony J Giovinazzo
Chairman,director
BoughtC$1737
Dec 16, 2023
Anthony J Giovinazzo
Chairman,director
BoughtC$25665

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,997,770Insider99.95%7,191,972
1,905,000Insider95.30%6,858,000
1,815,000Insider90.80%6,534,000
1,664,315Insider83.26%5,991,534
750,284Insider37.54%2,701,022
510,000Insider25.51%1,836,000
67,957Insider3.40%244,645
9,625Insider0.48%34,650
8,500Insider0.43%30,600

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns XORTX Therapeutics Inc (XRTX)?
Currently, no data Available
What percentage of XORTX Therapeutics Inc (XRTX) stock is held by institutional investors?
Currently, no data Available
What percentage of XORTX Therapeutics Inc (XRTX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of XORTX Therapeutics Inc (XRTX)?
Allan William Williams owns the most shares of XORTX Therapeutics Inc (XRTX).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis